NCT01497587View on ClinicalTrials.gov

Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

DiabetesHealthy

Interventions

DRUG

insulin detemir

Single dose, 0.5 U/kg, administered s.c. (under the skin)

Trial Locations (1)

112

Novo Nordisk Investigational Site, Taipei

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01497587 - Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan | Biotech Hunter | Biotech Hunter